Developing medicinal product with AI

Artificial Intelligence (AI) can accelerate the development of medicines and promote personalised medicine across the board. In this way, better and individualised medicines can be brought to market more cost-effectively. However, before the population can benefit from more favourable drug prices and innovative medicines, sufficient high-quality data from patients must be made available for research in addition to data on active ingredients, and a legally secure regulatory framework must be created. A current white paper from Plattform Lernende Systeme uses practical examples to show the potential of AI in drug development and addresses design options for overcoming the existing hurdles.

Read the press release here.